Customer Story: St Andrews Medical School, UK Milestone's customized XProtect video platform for St Andrews Medical School empowers learning and aids in the development of students' practical skills. By: Milestonesys Continue reading
Tag Archives: the-development
Research and Markets: Personalized Medicine – Scientific and Commercial Aspects – Updated 2013 Report
DUBLIN–(BUSINESS WIRE)– Research and Markets (http://www.researchandmarkets.com/research/c247cv/personalized) has announced the addition of Jain PharmaBiotech’s new report “Personalized Medicine – Scientific and Commercial Aspects” to their offering. The aim of personalized medicine or individualized treatment is to match the right drug to the right patient and, in some cases, even to design the appropriate treatment for a patient according to his/her genotype. This report describes the latest concepts of development of personalized medicine based on pharmacogenomics, pharmacogenetics,pharmacoproteomics, and metabolomics Continue reading
BG Medicine to Announce First Quarter 2013 Financial Results and Host Conference Call on Thursday, May 9, 2013
WALTHAM, Mass., May 2, 2013 (GLOBE NEWSWIRE) — BG Medicine, Inc. (BGMD) today announced that the company will host a conference call and webcast on Thursday, May 9 at 8:30 a.m. Continue reading
Liberty Twp. retail development signs first tenant, changes site plans
LIBERTY TWP. The multimillion dollar mixed-used retail, residential and office development proposed for Liberty Twp. Continue reading
Economic Action Plan 2013 Delivers for Canadian Aerospace
OTTAWA, March 21, 2013 /CNW/ – The Aerospace Industries Association of Canada (AIAC) is very pleased with measures announced in the Economic Action Plan 2013 released today in Ottawa. “The measures announced in the 2013 Economic Action Plan constitute an excellent short-term response to the Aerospace Review report released in December,” said Jim Quick, President & CEO of AIAC. The Action Plan specifically addresses several Emerson Report recommendations in what the government qualifies as “early actions in response to the Aerospace Review.” These include: The government also committed to additional action over the coming year to “improve the focus and coordination of federal programs and practices.” “AIAC and its member companies look forward to supporting this government work, particularly with respect to the space industry,” said Mr Continue reading
BG Medicine to Announce Fourth Quarter and Year-End 2012 Financial Results and Host Conference Call on Wednesday …
WALTHAM, Mass., March 6, 2013 (GLOBE NEWSWIRE) — BG Medicine, Inc. (BGMD) today announced that the company will host a conference call and webcast on Wednesday, March 13 at 8:30 a.m. Eastern Time to discuss its fourth quarter and year-end 2012 financial results. Continue reading
BG Medicine, Inc. Announces Publication of Two Studies Supporting Repeat Galectin-3 Testing in Heart Failure Patients
WALTHAM, Mass., Feb. 27, 2013 (GLOBE NEWSWIRE) — BG Medicine, Inc. (BGMD), a diagnostics company focused on the development and commercialization of novel cardiovascular tests, announced today the publication of two studies demonstrating the clinical utility of repeated galectin-3 testing as a tool in the assessment of patients with heart failure Continue reading
BG Medicine, Inc. to Present at Cowen and Company 33rd Annual Health Care Conference
WALTHAM, Mass., Feb. 27, 2013 (GLOBE NEWSWIRE) — BG Medicine, Inc. (BGMD) ), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that Eric Bouvier, BG Medicine’s President and CEO, will be presenting at the Cowen and Company 33rd Annual Health Care Conference on March 4, 2013, at the Boston Marriott Copley Place, beginning at 2:10 PM Eastern Time (ET) Continue reading
Jennerex Announces Nature Medicine Publication Highlighting Randomized Overall Survival Benefit of Lead Product …
SAN FRANCISCO, CA–(Marketwire – Feb 10, 2013) – Jennerex, Inc., a private, clinical-stage biotherapeutics company focused on the development and commercialization of best-in-class targeted oncolytic immunotherapies for solid tumors, today announced the publication of research demonstrating the ability of its lead product-candidate, Pexa-Vec (JX-594) to significantly prolong survival in advanced hepatocellular carcinoma (HCC) patients in a randomized dose comparison clinical trial. Continue reading
Nanotechnology Park Sri Lanka – Video
Nanotechnology Park Sri Lanka Located on 50 Acres of lush land, tranquil and verdant, creating an ideal space for'thinking', SLINTEC aims to develop a world-class Nanotechnology Park in Sri Lanka by attracting investments and establishing collaborations with local as well as global companies. Perfectly connected via highways, surrounded by a knowledge hub of universities and only 45 minutes from the commercial center that is Colombo, the Park offers a perfect synergy of serenity and convenience. The Park creates opportunities for all businesses to develop new products through a collaborative innovation process, taking them from research through development toward commercialization Continue reading
Shaklee Business – What is Your Freedom Project and how is it related to the Shaklee Business – Video
Shaklee Business – What is Your Freedom Project and how is it related to the Shaklee Business Shaklee Business – To learn more about Your Freedom Project visit: Explore.MyDreamSpots.com Your Freedom Project is the Shaklee business reinforced. Continue reading
NOCSAE Agrees to Fund More Than $855,000 in Sports Medicine and Concussion Research
OVERLAND PARK, Kan., Jan. 31, 2013 /PRNewswire/ — The National Operating Committee on Standards for Athletic Equipment (NOCSAE) today announced an agreement to fund $855,657 in sports medicine and concussion research. Continue reading
BG Medicine, Inc. Announces Closing of Public Offering and Exercise of Over-Allotment Option
WALTHAM, Mass., Jan. 30, 2013 (GLOBE NEWSWIRE) — BG Medicine, Inc. (BGMD), a diagnostics company focused on the development and commercialization of novel cardiovascular tests, today announced the closing of its previously announced public offering of 6,000,000 shares of its common stock, as well as 900,000 additional shares of its common stock pursuant to the full exercise of the over-allotment option granted to the underwriter. Continue reading
Micronova – Aalto University and VTT Centre for Micro and Nanotechnology – Video
Micronova – Aalto University and VTT Centre for Micro and Nanotechnology Micronova is Finland's National Research Infrastructure for micro- and nanotechnology, jointly run by VTT Technical Research Centre of Finland and Aalto University. Micronova's expertise covers the entire micro-nano innovation chain, from basic device physics and materials research to the development of new fabrication techniques and device prototypes, and even small scale manufacturing Continue reading
Super Cyborg trailer – Video
Super Cyborg trailer Super Cyborg is an indie 8-bit platformer shooter. Continue reading
Potential stem cell therapy for Duchenne’s
By Sally Robertson, medwireNews Reporter Researchers have found that injecting aorta-derived stem cells into the hearts of dystrophin-deficient mice prevents the onset of dilated cardiomyopathy (DCM), raising hopes of a potential new treatment approach to prevent or reverse the condition in human Duchenne muscular dystrophy. “This is the first report of stem cell therapy yielding functional benefit in the dystrophin-deficient heart,” say Suzanne Berry (University of Illinois, Urbana, USA) and team. As reported in Stem Cells Translational Medicine, injection of wild-type aorta-derived mesoangioblasts (ADMs) containing a functional copy of the dystrophin gene, significantly improved heart function compared with deficient mice injected with saline (controls) Continue reading
Breitling Aerospace – Video
Breitling Aerospace Buy from Amazon US amzn.com Product Description Breitling Aerospace An expert manufacturer and pioneer of highly technical watches, Breitling has been a major player in the development of the wrist chronograph and is a leader in this feature. Continue reading
Scientists identify molecular mechanism central to development of osteoarthritis pain
Researchers at Rush University Medical Center, in collaboration with researchers at Northwestern University, have identified a molecular mechanism central to the development of osteoarthritis (OA) pain, a finding that could have major implications for future treatment of this often-debilitating condition. Continue reading
Nanoporous Materials Iii – , Abdel Sayari – Video
Nanoporous Materials Iii – , Abdel Sayari ll4.me Nanoporous Materials Iii – , Abdel Sayari Nanoporous Materials III contains the invited lectures and peer-reviewed oral and poster contributions to be presented at the 3rd Conference on Nanoporous Materials, which will be hosted in Ottawa, Canada, June 2002. Continue reading
Does Mankind Have a Future (Part 4 of 8) – Video
Does Mankind Have a Future (Part 4 of 8) Will humanity be'saved' by the development of Artificial Intelligence, will AI threaten the survival of anything we could still remotely regard as human, or will AI just simply decide to obliterate all life on Earth and then switch itself off?From:DerivedEnergyViews:0 5ratingsTime:11:48More inEducation Continue reading